Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell Microcap Growth Index
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.63 USD | +1.24% | +10.96% | +10.20% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.20% | 86.77M | |
-1.18% | 103B | |
+8.77% | 101B | |
+4.40% | 23.07B | |
-12.22% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.20% | 16.94B | |
+6.85% | 14.07B | |
+39.15% | 12.35B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell Microcap Growth Index